secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001641172-25-011084
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivos Q1 2025 product rev +8% YoY, net loss $3.9M; acquires Sleep Center of Nevada for up to $9M
--------------------------------------------------------------------------------

- Revenue $3.0M (-12% YoY) as pivot away from VIP service revenue; product revenue up 8% to $1.8M from appliance arch sales.
- Net loss $3.9M (+3% YoY); operating expenses $5.4M (-5% YoY) reflecting cost-cutting.
- Cash $2.3M, equity $4.4M at March 31, 2025.
- Entered definitive agreement on April 15, 2025 to acquire The Sleep Center of Nevada for up to $9M cash/stock; expected close within two months.
- Sold 3,736 oral appliance arches (vs 1,996 in Q1 2024) driving product revenue increase.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000164117225011084/0001641172-25-011084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000164117225011084/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-011084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer